Search

Your search keyword '"Ullmann, Andrew"' showing total 17 results
Start Over Author "Ullmann, Andrew" Language german
17 results on '"Ullmann, Andrew"'

1. Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie

Author

Laws, Hans-Jürgen, Baumann, Ulrich, Bogdan, Christian, Burchard, Gerd, Christopeit, Maximilian, Hecht, Jane, Heininger, Ulrich, Hilgendorf, Inken, Kern, Winfried, Kling, Kerstin, Kobbe, Guido, Külper, Wiebe, Lehrnbecher, Thomas, Meisel, Roland, Simon, Arne, Ullmann, Andrew, de Wit, Maike, and Zepp, Fred

Published
2020
Full Text
View/download PDF

2. Erratum zu: Impfen bei Immundefizienz: Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (III) Impfen bei hämatologischen und onkologischen Erkrankungen (antineoplastische Therapie, Stammzelltransplantation), Organtransplantation und Asplenie

Author

Laws, Hans-Jürgen, Baumann, Ulrich, Bogdan, Christian, Burchard, Gerd, Christopeit, Maximilian, Hecht, Jane, Heininger, Ulrich, Hilgendorf, Inken, Kern, Winfried, Kling, Kerstin, Kobbe, Guido, Külper, Wiebe, Lehrnbecher, Thomas, Meisel, Roland, Simon, Arne, Ullmann, Andrew, de Wit, Maike, and Zepp, Fred

Published
2020
Full Text
View/download PDF

7. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

Author

Schweizerische Gesellschaft Für Hämatologie, Maschmeyer, Georg, Lilienfeld-Toal, Marie Von, Schweizerische Gesellschaft Für Medizinische Onkologie, Silling, Gerda, Sandherr, Michael, Wolf, Hans-Heinrich, Liss, Blasius Janusch, Buchheidt, Dieter, Egerer, Gerlinde, Österreichische Gesellschaft Für Hämatologie & Medizinische Onkologie, Cornely, Oliver Andreas, Rieger, Christina Theresa, Hentrich, Marcus, Vehreschild, Maria J. G. T., Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Ullmann, Andrew, Lehners, Nicola, Heinz, Werner, Mayer, Karin Tina, and Mellinghoff, Sibylle Christiane

Subjects
Medizin und Gesundheit
Published
2019
Full Text
View/download PDF

8. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

Author

Karthaus, Meinolf, Penack, Olaf, Ritter, Jörg, Kurzai, Oliver, Maschmeyer, Georg, Lilienfeld-Toal, Marie Von, Schweizerische Gesellschaft Für Medizinische Onkologie, Schmidt-Hieber, Martin, Buchheidt, Dieter, Rieger, Christina Theresa, Schwartz, Stefan, Rickerts, Volker, Hamprecht, Axel, Heinz, Werner, Schuelper, Nikolai, Schweizerische Gesellschaft Für Hämatologie, Weber, Thomas, Wolf, Hans-Heinrich, Vehreschild, Jörg Janne, Horger, Marius Stefan, Österreichische Gesellschaft Für Hämatologie & Medizinische Onkologie, Heußel, Claus Peter, Deutsche Gesellschaft Für Hämatologie Und Onkologie. Arbeitsgemeinschaft Infektiologie, Löffler, Jürgen, Christopeit, Maximilian Erich Joachim, Ruhnke, Markus, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Behre, Gerhard, and Ullmann, Andrew

Subjects
Medizin und Gesundheit
Published
2019
Full Text
View/download PDF

10. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

Author

Penack, Olaf, Schweizerische Gesellschaft Für Hämatologie, Kalkreuth, Jana, Lilienfeld-Toal, Marie Von, Maschmeyer, Georg, Weber, Thomas, Klein, Michael, Schweizerische Gesellschaft Für Medizinische Onkologie, Silling, Gerda, Kochanek, Matthias, Wolf, Hans-Heinrich, Hauf, Elke, Schalk, Enrico, Österreichische Gesellschaft Für Hämatologie & Medizinische Onkologie, Berger, Annemarie, Heußel, Claus Peter, Rieger, Christina Theresa, Christopeit, Maximilian Erich Joachim, Hentrich, Marcus, Vehreschild, Maria J. G. T., Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Lehners, Nicola, Ullmann, Andrew, and Mayer, Karin Tina

Subjects
Medizin und Gesundheit
Published
2018
Full Text
View/download PDF

11. Stellungnahme zur Nutzenbewertung des IQWiG gemäß § 35a SGB V, Vorgangsnummer 2015-11-15-D-192, G-BA Bericht, veröffentlicht am 15. Februar 2016, IQWiG Bericht Nr. 360, veröffentlicht am 2. Februar 2016

Author

Mousset, Sabine, Ostermann, Helmut, Maschmeyer, Georg, Wörmann, Bernhard, Cornely, Oliver Andreas, Deutsche Krebsgesellschaft. Arbeitsgemeinschaft Für Internistische Onkologie, Deutschland. Gemeinsamer Bundesausschuss, Ullmann, Andrew, and Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie. Arbeitsgemeinschaft Für Internistische Onkologie

Subjects
Medizin und Gesundheit
Published
2016
Full Text
View/download PDF

12. [Infectious diseases as a clinical specialty in Germany and Europe]

Author

Kern, Winfried V, Fätkenheuer, Gerd, Tacconelli, Evelina, and Ullmann, Andrew

Subjects
Cross Infection, Infectious Disease Medicine, rationale Antibiotikaverordnung, Drug Resistance, antibiotic stewardship, Drug Resistance, Microbial, Bacterial Infections, Continuing, healthcare quality, Infektiologie, ärztliche Weiterbildung, Education, Anti-Bacterial Agents, Europe, Microbial, Medical, Germany, Behandlungsqualität, Infectious diseases specialty, postgraduate training, Education, Medical, Continuing, Guideline Adherence, Humans, Specialization
Abstract

Clinical infectious diseases have only slowly been established as a medical specialty in Germany. The density of infectious diseases (ID) specialists and the number of ID divisions in general hospitals is still limited when compared with the situation in many other European countries, and there is also a lack of hospital-based medical microbiologists and infection control doctors for many reasons. Often, there is a lack of understanding of the roles and the performance of ID specialists versus microbiologists. Experience in other countries shows that ID specialists are important as clinical experts at the bedside, can help ascertain healthcare quality and patient safety, and are perfectly suited for undertaking strategic tasks in the field of cost-effective antimicrobial therapy algorithms and antibiotic stewardship (ABS) in hospitals. ID specialists are responsible for infection control in several countries, can improve the utility of diagnostic microbiology and are key partners in translational research. We estimate that more than 1,000 additional ID specialists are needed in this country, and believe that specially trained ABS experts can take over parts of their responsibilities and tasks in smaller hospitals. More capacity and flexibility in postgraduate training in infectious diseases, antibiotic stewardship and infection control in Germany will be critical to address the problem of antimicrobial resistance. (As supplied by publisher).

Published
2015

14. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

Author

Karthaus, Meinolf, Penack, Olaf, Ritter, Jörg, Krüger, William H., Maschmeyer, Georg, Krause, Stefan, Böhme, Angelika, Sandherr, Michael, Wolf, Hans-Heinrich, Vehreschild, Jörg Janne, Buchheidt, Dieter, Sieniawski, Michael, Deutsche Gesellschaft Für Hämatologie Und Onkologie. Arbeitsgemeinschaft Infektiologie, Cornely, Oliver Andreas, Ruhnke, Markus, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Ullmann, Andrew, Heinz, Werner, and Einsele, Hermann

Subjects
Medizin und Gesundheit
Published
2012
Full Text
View/download PDF

15. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen

Author

Bertz, Hartmut, Waldschmidt, Dirk Thomas, Karthaus, Meinolf, Penack, Olaf, Salwender, Hans, Krüger, William H., Sandherr, Michael, Wolf, Hans-Heinrich, Kiehl, Michael G., Buchheidt, Dieter, Egerer, Gerlinde, Reuter, Stefan, Cornely, Oliver Andreas, Auner, Holger, Ruhnke, Markus, Weißinger, Florian, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Ullmann, Andrew, and Heinz, Werner

Subjects
Medizin und Gesundheit
Published
2012
Full Text
View/download PDF

16. [Current development in the diagnostics and therapy of systemic fungal infections in cancer patients].

Author

Karthaus M, Ullmann AJ, and Cornely OA

Subjects
Adult, Antifungal Agents therapeutic use, Antigens, Fungal blood, Antineoplastic Agents therapeutic use, Aspergillosis diagnosis, Aspergillosis drug therapy, Candidiasis diagnosis, Candidiasis drug therapy, Child, Drug Therapy, Combination, Enzyme-Linked Immunosorbent Assay, Humans, Mycological Typing Techniques, Mycoses drug therapy, Opportunistic Infections drug therapy, Polymerase Chain Reaction, Antineoplastic Agents adverse effects, Leukemia therapy, Mycoses diagnosis, Neoplasms therapy, Opportunistic Infections diagnosis, Palliative Care, Stem Cell Transplantation
Abstract

Invasive fungal infections are associated with a high morbidity and mortality. They are of growing concern and a severe infectious complication in cancer patients treated with intensive chemotherapy. Within the last five years substantial progress has been demonstrated for non-culture based diagnostics and treatment of invasive fungal infections. Recent developments in the epidemiology, diagnostics and treatment of fungal infections are reviewed and discussed in the context of the current state of art for the management of invasive fungal infections in cancer patients.

Published
2004
Full Text
View/download PDF

17. [Vaccination of the immunocompromised host].

Author

Ullmann AJ, Karthaus M, and Cornely OA

Subjects
Evidence-Based Medicine, Humans, Immune Tolerance immunology, Leukemia immunology, Lymphoma immunology, Opportunistic Infections immunology, Risk Factors, Leukemia therapy, Lymphoma therapy, Opportunistic Infections prevention & control, Palliative Care, Stem Cell Transplantation, Vaccination
Abstract

Vaccinations are safe and effective in immunocompromised patients. Apparently most vaccines in this patient population are underutilized. General vaccination recommendations are expressed for influenza, diphtheria and tetanus. Pneumococcal, meningococcal und Haemophilus influenzae B immunizations are specially indicated for patients with or developing B-cell-deficiency. Live attenuated vaccines are usually contraindicated. The efficacy of the immunization and its indication can be additionally measured by antibody response, which is usually decreased compared to healthy subjects. Immunocompromised hosts with cancer will benefit from consistent immunization practices. Further clinical trials are urgently warranted.

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results